ArticleAnnals of surgical oncology2024

Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.

Jonathan S Zager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.